Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.75 - $4.18 $3,150 - $17,556
-4,200 Reduced 17.65%
19,600 $17,000
Q1 2024

May 15, 2024

BUY
$3.2 - $5.83 $53,440 - $97,361
16,700 Added 235.21%
23,800 $97,000
Q4 2023

Feb 14, 2024

SELL
$4.34 - $5.93 $59,024 - $80,648
-13,600 Reduced 65.7%
7,100 $41,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.3 $80,937 - $109,710
20,700 New
20,700 $106,000

Others Institutions Holding AUGX

About Augmedix, Inc.


  • Ticker AUGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,421,200
  • Market Cap $87.9M
  • Description
  • Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...
More about AUGX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.